作者:Zhong Chen、Soong-Hoon Kim、Stephanie A. Barbosa、Tram Huynh、David R. Tortolani、Kenneth J. Leavitt、Donna D. Wei、Veeraswamy Manne、Carolyn S. Ricca、Johnni Gullo-Brown、Michael A. Poss、Wayne Vaccaro、Mark E. Salvati
DOI:10.1016/j.bmcl.2005.10.052
日期:2006.2
The synthesis and SAR of a series of pyrrolopyridazine MEK inhibitors are reported. Optimal activity was achieved by incorporation of a 4-phenoxyaniline substituent at C4 and an acylated amine at C6.
PYRROLOPYRIDAZINE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF PROLIFERATIVE DISORDERS
申请人:Bristol-Myers Squibb Company
公开号:EP1664051A2
公开(公告)日:2006-06-07
US7030112B2
申请人:——
公开号:US7030112B2
公开(公告)日:2006-04-18
[EN] PYRROLOPYRIDAZINE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF PROLIFERATIVE DISORDERS<br/>[FR] COMPOSES DE PYRROLOPYRIDAZINE, ET PROCEDES POUR LES UTILISER POUR TRAITER DES TROUBLES DE PROLIFERATION
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2005030144A2
公开(公告)日:2005-04-07
Disclosed are pyrrolopyridazine compounds, methods of preparing such compounds, and their use for the treatment of proliferative, inflammatory, and other disorders.